Viewing Study NCT06736561

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:22 PM
Ignite Modification Date: 2026-02-22 @ 8:10 AM
Study NCT ID: NCT06736561
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-12-16
First Post: 2024-12-12
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Multicenter Real-world Clinical Study on the Efficacy and Safety of Ensartinib As Neoadjuvant Treatment for Anaplastic Lymphoma Kinase (ALK) Positive Non-small Cell Lung Cancer (NSCLC) Patients.
Sponsor: Harbin Medical University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None ALK Positive View
None Ensartinib View
None NSCLC View
None Neoadjuvant Therapy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ALK Positive View
None Ensartinib View
None NSCLC View
None Neoadjuvant therapy View